About

Biopharma Bytes

We deliver concise, biotech-first updates on the advances that move therapies from lab to patient—spanning R&D, CMC, and manufacturing. Based in Cambridge, Massachusetts, we turn complex science into practical takeaways for a professional biotech audience.

Some topics we cover:

Supply chain & raw materials (media, resins, critical reagents)

Gene editing (CRISPR, base/prime editing)

Cell & gene therapy (CAR-T/NK, AAV, lentiviral)

Stem-cell & regenerative medicine

Vaccines and immunotherapies (mRNA, viral vectors, adjuvants)

Biologics development (mAbs, bispecifics, ADCs)

Microbial & mammalian bioprocessing (E. coli, Bacillus, yeast, CHO)

Process development & intensification (DoE, PAT, QbD; fed-batch, perfusion, continuous)

CDMO/CMO market moves (capacity, partnerships, M&A, pricing)

GMP manufacturing (upstream/downstream, single-use, scale-up/tech transfer)

Analytical & QC (HPLC/LC-MS, qPCR/NGS, bioassays, comparability)

Formulation & delivery (LNPs, hydrogels, lyophilization, stability)

Precision medicine & biomarkers (multi-omics, companion diagnostics)

Regulatory & CMC (IND/BLA, validation, data integrity)

Clinical milestones (Ph I–III readouts, safety/efficacy signals)

Digital bioprocessing (automation, LIMS/ELN, AI/ML for yield and quality)

Want to learn more about cool science topics? Check out our Biopharma Blog.

Follow us on Linkedin here:

https://www.linkedin.com/company/biopharmabytes/